TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07667348: Return to Activity After Surgery for Lumbar Disc Herniation

Sponsor: Intrinsic Therapeutics · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 120 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,499,200

Rescue Site Savings

+$5,604,160

Unlock Full NCT07667348 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07667348 Rescue Dossier →